By this reason, it is speculated that SN09-2 may function through uncharacterized membrane proteins, but its final destination is likely to be mitochondria in a prostate cancer cell-specific manner, which is distinct from GnRH receptor-mediated endocytosis. The gene discussed is GNRHR; the disease is prostate cancer.